HIV inhibitors of formula (I) wherein R1 is halo, C1-4 alkoxy, trifluoromethoxy； R2 is a group of formula (A)； R3 is a group of formula (B)； R4 is a group of formula (C)； n is 0 or 1； A is CH or N； R5 and R6 are hydrogen, C1-4 alkyl, halo； R7 and R8 are C1-4 allyl or C1-4 alkoxy-C1-4 alkyl； R9 is C1-4 allyl, cyclopropyl, trifluoromethyl, C1-4 alkoxy, or dimethylamino； R10 is hydrogen, C1-4 alkyl, cyclopropyl, trifluoromethyl, C1-4 alkoxy, or dimethylamino； pharmaceutically acceptable addition salts and solvates thereof； pharmaceutical compositions containing these compounds as active ingredient and processes for preparing said compounds.
